The infant, child, and maternal probiotic supplements market is projected to reach US$ 1,081.70 million by 2028 from US$ 604.94 million in 2021. It is expected to grow at a CAGR of 8.7% from 2022 to 2028.

Probiotics are live micro-organisms that promote good digestive health and help to improve human gut health. They play a vital role in preventive healthcare as they prevent the occurrence of diseases by strengthening the immune system. Gut health has become one of the prime health concerns among consumers. Increasing awareness regarding the benefits of probiotics has surged their popularity in infant, child, and maternal women health supplements. These factors are significantly driving the global demand for infant, child, and maternal probiotic supplements.

Moreover, probiotic strains, especially Bifidobacteria and lactobacillus, have favorable effects on the clearance of influenza viruses. This factor influenced the purchasing decisions of consumers. According to a survey conducted by Fonterra Co-operative, immune health was a stronger driver for purchasing probiotic supplements for infants and children than digestive health in China, Brazil, and the UAE. Thus, the COVID-19 pandemic created a massive demand for infant, child, and maternal probiotic supplements. However, due to the operational difficulties and raw material and labor shortages, there was a shortfall in production volumes, which led to the demand and supply gap. In response to the rising demand, manufacturers with more inventories could meet the demand, while companies with exhausted inventories incurred losses.

A few players operating in the infant, child, and maternal probiotic supplements market are Bayer Corporation; Nestle S.A.; Mommy’s Bliss Inc.; LoveBug Probiotics; Biogaia AB; MaryRuth Organics, LLC; Pharmavite LLC; Evolve Biosystems; Biomeology; and Nordic Naturals; and among few others.

Moreover, governments of North American countries are taking initiatives to improve infant and children's health. For instance, Healthy Start is one initiative to improve childhood health care. This initiative is designed to reduce the infant mortality rate and improve prenatal health in the region. Hence, the prenatal and postnatal use of probiotic supplements is further surging the growth of the infant, child, and maternal probiotic supplements market across North America.

Based on form, the market is segmented into capsules and soft gels, gummies, liquid, and others. Based on end user, the market is segmented into infants and toddlers, children, and maternal women. Based on geography, the market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW).

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

The Insight Partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com